Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Drug Discovery Today|December 26, 2021
Experimental murine models of brainstem gliomasShuting Ni, Rujing Chen, Kaili Hu
Biomaterials|January 29, 2024
Nanomedicines for reversing immunosuppressive microenvironment of hepatocellular carcinomaXier Pan, Shuting Ni, Kaili Hu
International Immunopharmacology|October 30, 2024
The emerging role of microglia in the development and therapy of multiple sclerosisYunrong Nan, Shuting Ni, Mei Liu, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 2, 2024
Biomimetic "nano-spears" for CAFs-targeting: splintered three "shields" with enhanced cisplatin anti-TNBC efficiencyYufan Wu, Rujing Chen, Shuting Ni, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 26, 2023
Intranasal delivery of Borneol/R8dGR peptide modified PLGA nanoparticles co-loaded with curcumin and cisplatin alleviate hypoxia in pediatric brainstem glioma which improves the synergistic therapyXiao Zhao, Shuting Ni, Yangjie Song, et al.
Dialogues in Health|May 6, 2026
Global trend and disparity in the burden of ischemic stroke attributable to high body-mass index from 1990 to 2021 and projection to 2050: a systematic analysis based on the Global Burden of Disease Study 2021Shuting Ni, Ying Zhang, Shilei Lin, et al.
International Journal of Nanomedicine|August 11, 2021
Improved Anti-Triple Negative Breast Cancer Effects of Docetaxel by RGD-Modified Lipid-Core MicellesRujing Chen, Shuting Ni, Wangyan Chen, et al.
Acta Pharmaceutica Sinica. B|June 9, 2025
Nano-drug delivery strategies affecting cancer-associated fibroblasts to reduce tumor metastasisLinghui Zou, Peng Xian, Qing Pu, et al.
IEEE Transactions on Visualization and Computer Graphics|March 8, 2024
Enhancing Tai Chi Training System: Towards Group-Based and Hyper-Realistic Training ExperiencesFeng Tian, Shuting Ni, Xiaoyue Zhang, et al.
International Journal of Pharmaceutics|August 28, 2023
Nose to brain delivery of Astragaloside IV by β-Asarone modified chitosan nanoparticles for multiple sclerosis therapyXiao Zhao, Lixue Sun, Jing Wang, et al.
Pageof 2